Conflict of Interest Policy
Conflict of Interest Disclosure and Management Policy
The Journal of Pharmacovigilance and Drug Research (JPADR) is committed to maintaining the highest standards of integrity, transparency, and ethical publishing practices.
All participants involved in the publication process—including authors, reviewers, editors, and Editorial Board members—are required to disclose any conflicts of interest that could influence, or reasonably appear to influence, their responsibilities and professional judgment.
JPADR follows the ethical recommendations of the Committee on Publication Ethics (COPE) and the International Committee of Medical Journal Editors (ICMJE) regarding disclosure and management of conflicts of interest.
1. Definition of Conflict of Interest
A Conflict of Interest (COI) exists when professional judgment regarding a primary interest—such as scientific integrity, objectivity, or patient welfare—may be influenced by a secondary interest.
Conflicts of interest may be:
- Financial
- Academic
- Professional
- Institutional
- Personal
- Political or ideological
The existence of a conflict of interest does not necessarily prevent publication or participation in the editorial process. However, complete disclosure is mandatory to ensure transparency and informed editorial decision-making.
2. Conflict of Interest Policy for Authors
2.1 Author Disclosure Requirements
All authors must disclose any financial or non-financial relationships that could influence or appear to influence the submitted work.
Authors should disclose:
- Sources of funding.
- Financial support.
- Research grants and contracts.
- Consultancy fees.
- Honoraria.
- Employment relationships.
- Stock ownership or equity interests.
- Patents or patent applications.
- Paid expert testimony.
- Membership on advisory boards.
- Sponsored travel or accommodation.
- Institutional affiliations with commercial organizations.
Non-financial conflicts may include:
- Academic competition.
- Strong intellectual or scientific beliefs.
- Personal relationships.
- Institutional rivalries.
- Political or ideological commitments related to the manuscript.
2.2 Financial Conflicts of Interest
Examples include:
- Employment by pharmaceutical or healthcare companies.
- Industry-sponsored research.
- Participation in speaker bureaus.
- Equity ownership or stock options.
- Royalties.
- Paid consultancy services.
Relevant financial relationships during the previous three years should be disclosed.
2.3 Academic and Professional Conflicts
Examples include:
- Competition between research groups.
- Direct academic rivalry.
- Ongoing collaborative disputes.
- Intellectual bias based on previous publications.
- Competing grants or patent interests.
2.4 Personal Conflicts
Examples include:
- Family relationships.
- Personal friendships.
- Personal disputes.
- Mentor–trainee relationships.
- Institutional or departmental conflicts.
2.5 Conflict of Interest Statement
Every submitted manuscript must include a Conflict of Interest Statement immediately before the References section.
Example (Conflicts Exist)
The authors declare that Author A received research funding from XYZ Pharmaceuticals. Author B has served as a consultant for ABC Healthcare.
Example (No Conflicts)
The authors declare that there are no conflicts of interest regarding the publication of this manuscript.
Failure to disclose relevant conflicts may constitute publication misconduct.
3. Conflict of Interest Policy for Reviewers
Peer reviewers are expected to evaluate manuscripts objectively, fairly, and confidentially.
Reviewers should decline review assignments whenever a conflict of interest may compromise, or reasonably appear to compromise, their impartiality.
3.1 Reviewer Conflicts May Include
Financial Conflicts
- Employment by competing organizations.
- Financial interests in products discussed.
- Industry-sponsored research relationships.
Academic Conflicts
- Recent collaboration with the authors.
- Direct scientific competition.
- Recent co-authorship.
- Academic rivalry.
Personal Conflicts
- Family or personal relationships.
- Institutional conflicts.
- Professional disputes.
3.2 Reviewer Responsibilities
Reviewers are expected to:
- Disclose any potential conflicts immediately.
- Decline review assignments when impartiality cannot be maintained.
- Avoid using unpublished information for personal advantage.
- Maintain strict confidentiality throughout the review process.
Reviewers must not contact authors directly regarding manuscripts under review.
4. Conflict of Interest Policy for Editors and Editorial Board Members
Editors and Editorial Board members must ensure fair, objective, and unbiased editorial decision-making.
Editorial decisions should be based solely on:
- Scientific merit.
- Originality.
- Ethical compliance.
- Relevance to the journal's scope.
Editors must not be influenced by:
- Commercial interests.
- Institutional relationships.
- Personal relationships.
- Political or ideological considerations.
4.1 Editorial Conflicts Include
Financial Conflicts
- Consultancy relationships.
- Paid advisory roles.
- Industry funding.
- Financial investments.
Academic Conflicts
- Collaboration with authors.
- Institutional competition.
- Previous academic disputes.
Personal Conflicts
- Family relationships.
- Close personal friendships.
- Hostile or adversarial relationships.
4.2 Management of Editorial Conflicts
Editors with a conflict of interest regarding a manuscript should:
- Recuse themselves from editorial handling.
- Delegate editorial responsibility to another qualified editor.
- Avoid influencing peer review or publication decisions.
Where necessary, the journal may appoint an independent editor.
5. Disclosure Requirements
All disclosures should:
- Be complete and accurate.
- Include relevant relationships from the previous three years.
- Be updated if circumstances change during review or publication.
JPADR reserves the right to request clarification or supporting documentation where necessary.
Incomplete or misleading disclosures may result in:
- Manuscript rejection.
- Publication of a correction.
- Retraction of the published article.
- Notification to institutions or funding agencies where appropriate.
6. Funding Transparency
Authors must clearly disclose all sources of financial support received for the conduct of the research and preparation of the manuscript.
Funding disclosures should include:
- Funding agencies or sponsoring organizations.
- Grant numbers, where applicable.
- Institutional funding support.
- Industry sponsorship.
- Research contracts.
Authors should also describe the role of the funding organization in:
- Study design.
- Data collection.
- Data analysis.
- Interpretation of results.
- Manuscript preparation.
- Decision to submit the manuscript for publication.
If the funding agency had no involvement in the research process, authors should explicitly state this.
Example Funding Statement
The funding agency had no role in study design, data collection, data analysis, interpretation of results, manuscript preparation, or the decision to publish.
7. Management of Conflicts of Interest
JPADR evaluates all disclosed conflicts of interest on a case-by-case basis to ensure transparency while preserving scientific integrity.
Depending on the nature and extent of the disclosed conflict, the journal may implement one or more of the following management strategies:
- Publication of Conflict of Interest disclosure statements.
- Assignment of additional independent peer reviewers.
- Enhanced editorial oversight.
- Replacement of reviewers or editors with conflicts.
- Editorial recusal from decision-making.
- Independent statistical or methodological review.
- Rejection of the manuscript in severe cases.
The purpose of conflict management is to maintain transparency, fairness, and confidence in the editorial process rather than automatically excluding individuals with disclosed conflicts.
8. Undisclosed Conflicts of Interest
If a conflict of interest is identified before or after publication that was not properly disclosed, JPADR may initiate an editorial investigation.
Depending on the findings, the journal may:
- Request clarification from the authors.
- Request correction of the published disclosure statement.
- Publish a Corrigendum or Erratum.
- Issue an Expression of Concern.
- Retract the published article where appropriate.
- Notify the relevant institution, employer, or funding agency.
Investigations will be conducted in accordance with the recommendations and flowcharts of the Committee on Publication Ethics (COPE).
9. Confidentiality and Ethical Responsibility
Conflict of Interest disclosures submitted to the journal will be handled confidentially during the editorial and peer-review process.
Editors and reviewers are expected to:
- Maintain confidentiality of all submitted manuscripts.
- Protect confidential disclosure information.
- Avoid misuse of unpublished data.
- Handle manuscripts ethically and impartially.
Disclosure information will be used solely for editorial assessment and ethical decision-making.
10. Compliance with Ethical Standards
By submitting, reviewing, or editing manuscripts for JPADR, all participants agree to comply with:
- The journal's ethical policies.
- International publication ethics standards.
- Principles of transparency.
- Research integrity requirements.
- Conflict of Interest disclosure obligations.
Failure to comply with this policy may result in one or more of the following actions:
- Rejection of the manuscript.
- Removal from the reviewer database.
- Removal from editorial responsibilities.
- Retraction of published work.
- Notification to affiliated institutions where appropriate.
JPADR is committed to maintaining transparency, objectivity, and public trust through responsible disclosure and management of conflicts of interest.
References
- International Committee of Medical Journal Editors (ICMJE). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals: Disclosure of Relationships and Activities.
- Committee on Publication Ethics (COPE). Core Practices and Ethical Guidelines.
Policy Review
This Conflict of Interest Disclosure and Management Policy is reviewed periodically by the Editorial Board to ensure continued alignment with international ethical publishing standards, evolving best practices, and the recommendations of organizations such as ICMJE and COPE.
The most recent version of this policy will always be available on the official JPADR website.
